Literature DB >> 27452268

Evaluation of uterine ultrasound imaging in cervical radiotherapy; a comparison of autoscan and conventional probe.

Mariwan Baker1,2,3, David T Cooper4, Claus F Behrens1.   

Abstract

OBJECTIVE: In cervical radiotherapy, it is essential that the uterine position is correctly determined prior to treatment delivery. The aim of this study was to evaluate an autoscan ultrasound (A-US) probe, a motorized transducer creating three-dimensional (3D) images by sweeping, by comparing it with a conventional ultrasound (C-US) probe, where manual scanning is required to acquire 3D images.
METHODS: Nine healthy volunteers were scanned by seven operators, using the Clarity(®) system (Elekta, Stockholm, Sweden). In total, 72 scans, 36 scans from the C-US and 36 scans from the A-US probes, were acquired. Two observers delineated the uterine structure, using the software-assisted segmentation in the Clarity workstation. The data of uterine volume, uterine centre of mass (COM) and maximum uterine lengths, in three orthogonal directions, were analyzed.
RESULTS: In 53% of the C-US scans, the whole uterus was captured, compared with 89% using the A-US. F-test on 36 scans demonstrated statistically significant differences in interobserver COM standard deviation (SD) when comparing the C-US with the A-US probe for the inferior-superior (p < 0.006), left-right (p < 0.012) and anteroposterior directions (p < 0.001). The median of the interobserver COM distance (Euclidean distance for 36 scans) was reduced from 8.5 (C-US) to 6.0 mm (A-US). An F-test on the 36 scans showed strong significant differences (p < 0.001) in the SD of the Euclidean interobserver distance when comparing the C-US with the A-US scans. The average Dice coefficient when comparing the two observers was 0.67 (C-US) and 0.75 (A-US). The predictive interval demonstrated better interobserver delineation concordance using the A-US probe.
CONCLUSION: The A-US probe imaging might be a better choice of image-guided radiotherapy system for correcting for daily uterine positional changes in cervical radiotherapy. ADVANCES IN KNOWLEDGE: Using a novel A-US probe might reduce the uncertainty in interoperator variability during ultrasound scanning.

Entities:  

Mesh:

Year:  2016        PMID: 27452268      PMCID: PMC5124817          DOI: 10.1259/bjr.20160510

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  17 in total

1.  Prostate boundary segmentation from 2D ultrasound images.

Authors:  H M Ladak; F Mao; Y Wang; D B Downey; D A Steinman; A Fenster
Journal:  Med Phys       Date:  2000-08       Impact factor: 4.071

2.  Online ultrasound image guidance for radiotherapy of prostate cancer: impact of image acquisition on prostate displacement.

Authors:  Xavier Artignan; Monique H P Smitsmans; Jos V Lebesque; David A Jaffray; Marcel van Her; Harry Bartelink
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-06-01       Impact factor: 7.038

3.  Ultrasound probe pressure as a source of error in prostate localization for external beam radiotherapy.

Authors:  John P McGahan; Janice Ryu; Maria Fogata
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-11-01       Impact factor: 7.038

4.  Critical assessment of intramodality 3D ultrasound imaging for prostate IGRT compared to fiducial markers.

Authors:  Skadi van der Meer; Esther Bloemen-van Gurp; Jolanda Hermans; Robert Voncken; Denys Heuvelmans; Carol Gubbels; Davide Fontanarosa; Peter Visser; Ludy Lutgens; Francis van Gils; Frank Verhaegen
Journal:  Med Phys       Date:  2013-07       Impact factor: 4.071

5.  Quality assurance of U.S.-guided external beam radiotherapy for prostate cancer: report of AAPM Task Group 154.

Authors:  Janelle A Molloy; Gordon Chan; Alexander Markovic; Shawn McNeeley; Doug Pfeiffer; Bill Salter; Wolfgang A Tome
Journal:  Med Phys       Date:  2011-02       Impact factor: 4.071

Review 6.  Review of ultrasound image guidance in external beam radiotherapy: I. Treatment planning and inter-fraction motion management.

Authors:  Davide Fontanarosa; Skadi van der Meer; Jeffrey Bamber; Emma Harris; Tuathan O'Shea; Frank Verhaegen
Journal:  Phys Med Biol       Date:  2015-01-16       Impact factor: 3.609

7.  Impact of probe pressure variability on prostate localization for ultrasound-based image-guided radiotherapy.

Authors:  Marie Fargier-Voiron; Benoît Presles; Pascal Pommier; Simon Rit; Alexandre Munoz; Hervé Liebgott; David Sarrut; Marie-Claude Biston
Journal:  Radiother Oncol       Date:  2014-03-13       Impact factor: 6.280

8.  Initial experience with ultrasound localization for positioning prostate cancer patients for external beam radiotherapy.

Authors:  Christopher F Serago; Suzanne J Chungbin; Steven J Buskirk; Gary A Ezzell; A Craig Collie; Sujay A Vora
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-08-01       Impact factor: 7.038

9.  Inter- and intrafractional tumor and organ movement in patients with cervical cancer undergoing radiotherapy: a cinematic-MRI point-of-interest study.

Authors:  Philip Chan; Robert Dinniwell; Masoom A Haider; Young-Bin Cho; David Jaffray; Gina Lockwood; Wilfred Levin; Lee Manchul; Anthony Fyles; Michael Milosevic
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-31       Impact factor: 7.038

10.  Image-guided radiotherapy for prostate cancer. Implementation of ultrasound-based prostate localization for the analysis of inter- and intrafraction organ motion.

Authors:  Michael Pinkawa; Martin Pursch-Lee; Branka Asadpour; Bernd Gagel; Marc D Piroth; Jens Klotz; Sandra Nussen; Michael J Eble
Journal:  Strahlenther Onkol       Date:  2008-12-24       Impact factor: 3.621

View more
  1 in total

1.  Towards ultrasound-guided adaptive radiotherapy for cervical cancer: Evaluation of Elekta's semiautomated uterine segmentation method on 3D ultrasound images.

Authors:  Sarah A Mason; Tuathan P O'Shea; Ingrid M White; Susan Lalondrelle; Kate Downey; Mariwan Baker; Claus F Behrens; Jeffrey C Bamber; Emma J Harris
Journal:  Med Phys       Date:  2017-06-16       Impact factor: 4.071

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.